Boston Scientific
866 hedge funds and large institutions have $50.9B invested in Boston Scientific in 2022 Q3 according to their latest regulatory filings, with 82 funds opening new positions, 334 increasing their positions, 295 reducing their positions, and 85 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 334 | Existing positions reduced: 295
5% more funds holding in top 10
Funds holding in top 10: 21 → 22 (+1)
5% more capital invested
Capital invested by funds: $48.6B → $50.9B (+$2.35B)
0.38% more ownership
Funds ownership: 91.26% → 91.64% (+0.38%)
4% less first-time investments, than exits
New positions opened: 82 | Existing positions closed: 85
9% less call options, than puts
Call options by funds: $233M | Put options by funds: $255M
2% less funds holding
Funds holding: 880 → 866 (-14)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Amundi
Paris,
France
|
+$207M |
| 2 |
Goldman Sachs
New York
|
+$203M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$167M |
| 4 |
Impax Asset Management Group
London,
United Kingdom
|
+$85.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$78.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Parnassus Investments
San Francisco,
California
|
-$585M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$116M |
| 3 |
Neuberger Berman Group
New York
|
-$79.5M |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$70M |
| 5 |
Janus Henderson Group
London,
|
-$67.7M |
BSX Hedge Fund Activity: Q3 2022 in Review
866 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2022, worth a combined $50.9B — up 4.8% from $48.6B a quarter earlier.
Sellers outnumbered buyers: 85 funds closed out of BSX and 82 opened new positions — a net loss of 3 holders — while 295 trimmed existing stakes and 334 added.
The largest buyer was Amundi, adding an estimated $207M. The largest seller was Parnassus Investments, exiting entirely with an estimated $585M sold.
- 866 institutional investors held Boston Scientific (BSX) as of Q3 2022, down from 880 in Q2 2022.
- Funds reported $50.9B of Boston Scientific stock for Q3 2022, up 4.8% quarter-over-quarter.
- 82 funds opened new Boston Scientific positions in Q3 2022 and 85 closed out, a net change of -3 holders.
- The largest Boston Scientific buyer in Q3 2022 was Amundi, an estimated $207M added.
- The largest Boston Scientific seller in Q3 2022 was Parnassus Investments, an estimated $585M sold.
Based on aggregated 13F filings for Q3 2022.